![Jill Quigley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jill Quigley
Directeur/Membre du Conseil chez
CHEMOMAB THERAPEUTICS LTD.
Fortune : - $ au 30/06/2026
Profil
Jill Thompson Quigley is currently Chief Executive Officer at Genuiti Therapeutics, Inc., Chief Executive Officer at Stealth Biotech Co. since 2023, and Independent Director at Chemomab Therapeutics Ltd. since 2022.
Former roles include Chief Executive Officer & General Counsel at Nutrinia Ltd. from 2016 to 2018, Independent Director at Terns Pharmaceuticals, Inc. from 2020 to 2026, Assistant Corporate Counsel at Integra LifeSciences Holdings Corp.
from 2009 to 2011, Corporate Counsel at Pharmasset, Inc. from 2011 to 2012, Senior Legal Counsel at Shire Plc from 2012 to 2016, Associate at Dechert LLP from 2006 to 2009, Chief Operating Officer at Passage Bio, Inc. from 2018 to 2021, and Senior Counsel at NPS Pharmaceuticals, Inc. from 2012 to 2015.
Education includes an undergraduate degree from American University conferred in 1997 and a graduate degree from Rutgers Law School conferred in 2005.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Jill Quigley
| Sociétés | Poste | Début |
|---|---|---|
| CHEMOMAB THERAPEUTICS LTD. | Directeur/Membre du Conseil | 21/06/2022 |
Anciens postes connus de Jill Quigley
| Sociétés | Poste | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/05/2026 |
| PASSAGE BIO, INC. | Directeur des opérations | 31/12/2021 |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Develops bioactive feed supplements for infant formulas and animal feed | Directeur Général | 01/11/2018 |
| SHIRE | Conseiller Juridique Général | 01/01/2016 |
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2015 |
Formation de Jill Quigley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
American University
 American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
Nutrinia Ltd.
Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Develops bioactive feed supplements for infant formulas and animal feed | Health Technology |
Rutgers Law School
 Rutgers Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Chemomab Therapeutics Ltd.
 Chemomab Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biotech company | Health Technology |
